• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.20% Nasdaq Up0.41%

    More On IMC.AX



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Immuron Limited (IMC.AX)

    0.55 Up 0.06(12.24%) Oct 9, 12:21AM EDT
    ProfileGet Profile for:
    Immuron Limited
    18 Kavanagh Street
    Level 1
    Southbank, VIC 3006
    Australia - Map
    Phone: 61 3 8648 4530
    Fax: 61 3 9686 9460
    Website: http://www.immuron.com

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    Immuron Limited, a biopharmaceutical company, focuses on the research and development of polyclonal antibodies for the treatment and prevention of various diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. Its technology platform produces dairy colostrum- derived polyclonal antibodies used to treat a range of diseases, including infectious diseases, cancers, and chronic inflammatory diseases. The company markets Travelan, a product to prevent infection by enterotoxigenic escherichia coli, which is the cause of travelersÂ’ diarrhea. It is also developing IMM 124-E, a product in Phase II clinical trial for the treatment of non-alcoholic steatohepatitis/Type 2 diabetes; IMM 529 for the treatment of clostridium difficile infection; IMM-363 to treat of side effects caused by chemotherapy or radiation; and IMM-160 to reduce tumor size and suppress liver cancer. The company was founded in 1994 and is based in Southbank, Australia.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Immuron Limited

    Key Executives 
    Mr. Peter Anastasiou ,
    Exec. Vice Chairman
    Mr. Thomas Liquard , 43
    Chief Exec. Officer
    Mr. Phillip Allen Hains BBus(Acc), MBA, CA, 52
    Co-Chief Financial Officer and Company Sec.
    Mr. Peter Vaughan BBus(Acc), CA,
    Co-Chief Financial Officer and Company Sec.
    Dr. Jerry Kanellos ,
    Chief Operating and Scientific Officer
    Mr. David Lyon ,
    Head of Marketing
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in AUD.